Machine Learning HeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study of MyoVista wavECG Business Wire May 10, 2023 Heart Test Laboratories, d/b/a HeartSciences (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company…
Machine Learning HeartSciences Granted Key Israeli International Patent for its MyoVista Wavelet Technology Utilizing… AIT News Desk Feb 6, 2023 Heart Test Laboratories, . d/b/a HeartSciences, a medical technology company focused on saving lives by making an ECG (also known as an EKG) a far…
Machine Learning HeartSciences and Rutgers University Announce Multi-Year Collaboration to Develop AI-based ECG… AIT News Desk Dec 3, 2022 Heart Test Laboratories, d/b/a HeartSciences, a medical technology company focused on saving lives by making an ECG (also known as an EKG) a far more…
Machine Learning HeartSciences’ MyoVista Technology Used to Develop AI-ECG Algorithm to Identify Patients AIT News Desk Nov 13, 2022 Independent study demonstrates novel AI-ECG algorithm could provide a cost-effective strategy for improving cardiac risk stratification Heart Test…
Machine Learning HeartSciences Granted U.S Patent for ECG Assessment of Heart Diastolic Function Using Artificial… AIT News Desk Sep 21, 2022 Heart Test Laboratories, d/b/a HeartSciences , a medical technology company focused on applying innovative AI-based technology to an ECG (also known…